Approvals/TGA/PRAMOLE XR pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack

Approved

STANDARD

PRAMOLE XR pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c3d8a33b24633a62
Product Name: PRAMOLE XR pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack
Artg Id: 225630
Artg Name: PRAMOLE XR pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2015-06-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

c3d8a33b24633a62

Type

Standard